For most of the 39 cancers, there was no statistical correlation between ITGAV expression and TNM stage or clinical stage, except for adrenocortical carcinoma, LUAD, sarcoma, thyroid carcinoma, and LGG (Fig. 6B). Here, ITGAV is linked to sarcoma.